DJIA 18,024.06 183.54 1.03%
NASDAQ 5,005.39 63.97 1.29%
S&P 500 2,108.29 22.78 1.09%
market minute promo

Sarepta Therapeutics (NASDAQ: SRPT)



company name or ticker

Sarepta Therapeutics (SRPT) Stock Hits One-Year Low Today After Eteplirsen Update

Stocks Hitting 52-Week Lows

Why Sarepta Therapeutics Inc. Stock Tumbled 15% in December

Sarepta Therapeutics slumped by a double-digit percentage in December. Find out what's behind the move and whether or not shares are a bargain after their tumble.

Perilous Reversal Watch: Sarepta Therapeutics (SRPT)

PTC Therapeutics Starts Rolling NDA Filing for Translarna - Analyst Blog

PTC Therapeutics Starts Rolling NDA Filing for Translarna - Analyst Blog

Why Is George Soros Buying This Beaten Down Biotech Stock?

Soros Fund Management opened a position in the struggling biotech Aegerion Pharmaceuticals in the third quarter, even while the drugmaker's revenue estimates continued to plummet. Should retail investors follow his lead into this beaten down biotech?

Pfizer's Duchenne Muscular Dystrophy Drug in Phase II - Analyst Blog

Pfizer's Duchenne Muscular Dystrophy Drug in Phase II - Analyst Blog

2014 Healthcare Stock Report Card: Sobek Tracks His Hits and Misses

Twitter's Favorite Biotech and Pharma Stocks

Consensus? We don't need no stinking consensus!

Does George Soros Think Biotech's Bull Run Is Finally Coming to an End?

The Soros Fund Managment sold off a number of biotechs in the third quarter. Do the actions of this closely watched fund signal that the industry's bull run is finally winding down?
See More Articles...